Upper extremity arterial disease

Cardiology Clinics

Volumn 20, Issue 4, 2002, Pages 623-631

  Greenfield, Lazar J ^a   Rajagopalan, Sanjay ^b   Olin, Jeffrey W ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; FIBRINOLYTIC AGENT;

ANGIOPLASTY; ARM DISEASE; ARTERIOGRAPHY; ARTERY DISEASE; ARTERY OCCLUSION; ATHEROMA; ATHEROSCLEROSIS; CLAUDICATION; DOPPLER FLOWMETER; ENDARTERECTOMY; GANGRENE; HUMAN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; SKIN ULCER; STENT; THORAX RADIOGRAPHY; THROMBOEMBOLISM; VASOSPASM;

EID: 0036852614     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(02)00068-1     Document Type: Article

References (22)

1. Block JA, Sequeira W. Raynaud's phenomenon. Lancet 2001;357:2042-8.
2. McLafferty RB, Edwards JM, Ferris BL, Moneta GL, Taylor Jr LM, Landry GJ, et al. Raynaud's syndrome in workers who use vibrating pneumatic air knives. J Vasc Surg 1999;30:1-7.
3. Allen EV. Thromboangiitis obliterans. Methods of diagnosis of chronic occlusive arterial lesions distal to the wrist with illustrative cases. Am J Med Sci 1929;178:237-44.
4. Sumner DS. Volume plethysmography in vascular disease. In: Bernstein EF, editor. Vascular Diagnosis, 4th Edition. St Louis, MO: Mosby; 1993. p. 181-93.
5. Yao JST. Pressure measurement in the extremity. In: Bernstein EF, editor. Vascular Diagnosis, 4th Edition. St Louis, MO: Mosby; 1993. p. 169-75.
6. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343:864-9.
7. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
8. Yao JST. Upper extremity ischemia in athletes. Semin Vasc Surg 1998;2:96-105.
9. McLafferty RB, Edwards JM, Taylor Jr LM, Porter JM. Diagnosis and long-term clinical outcome in patients diagnosed with hand ischemia. Vasc Surg 1995;4:361-7.
10. Seibold JR. Critical tissue ischaemia in scleroderma: A note of caution. Ann Rheum Dis 1994;53:289-90.
11. Mills JL, Friedman EI, Taylor Jr LM, Porter JM. Upper extremity ischemia caused by small artery disease. Ann Surg 1987;206:521-8.
12. Phipp LH, Scott JA, Kessel D, et al. Subclavian stents and stent-grafts: Cause for concern? J Endovasc Surg 1999;6:223-6.
13. Mesh CL, Yao JST. Upper extremity bypass: Fiveyear follow-up. In: Yao JST, Pearce WH, editors. Long-Term Results in Vascular Surgery. Norwalk, CT: Appleton & Lange; 1993. p. 353-65.
14. Langford CA, Sneller MC, Hoffman GS. Methotrexate use in systemic vasculitis. Rheum Dis Clin N Am 1997;23:841-53.
15. Wilke WS, Hoffman GS. Treatment of corticosteroid-resistant giant cell arteritis. Rheum Dis Clin N Am 1995;21:59-71.
16. Stummvoll GH. Current treatment options in systemic sclerosis (scleroderma). Acta Med Austriaca 2002;29:14-9.
17. Melone Jr CP, McLoughlin JC, Beldner S. Surgical management of the hand in scleroderma. Curr Opin Rheumatol 1999;11:514-20.
18. Dean SM, Satiani B. Three cases of digital ischemia successfully treated with cilostazol. Vasc Med 2001; 6:245-8.
19. Sullivan TM, Gray BH, Bacharach JM, et al. Angioplasty and primary stenting of the subclavian, innominate, and common carotid arteries in 83 patients. J Vasc Surg 1998;28:1059-65.
20. Al-Mubarak N, Liu MW, Dean LS, et al. Immediate and late outcomes of subclavian artery stenting. Catheter Cardiovasc Interv 1999;46:169-72.
21. Lin PH, Bush RL, Weiss VJ, et al. Subclavian artery disruption resulting from endovascular intervention: Treatment options. J Vasc Surg 2000; 32:607-11.
22. Rodriguez-Lopez JA, Werner A, Martinez R, et al. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg 1991;13: 254-60.